Sungboon Editor Daily Invisible Blurring Sunscreen Cream
NDC Package 85037-002-04
Package Information
Sungboon Editor Daily Invisible Blurring Sunscreen (avobenzone, homosalate, octisalate, octocrylene) cream is helps prevent sunburn If used as directed with other sun protection measures (see Directions) decrease the risk of skin cancer and early skin aging caused by the sun. This formulation utilizes a cream delivery system. Marketed by Olive International Inc., this product is identified by NDC 85037-002 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85037 - Olive International Inc.
- 85037-002 - Sungboon Editor Daily Invisible Blurring Sunscreen
- 85037-002-04 - 1 TUBE in 1 CARTON / 12 mL in 1 TUBE (85037-002-03)
- 85037-002 - Sungboon Editor Daily Invisible Blurring Sunscreen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (85037-002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85037-002-04 identifies a specific commercial package of 1 tube in 1 carton / 12 ml in 1 tube (85037-002-03) of Sungboon Editor Daily Invisible Blurring Sunscreen, a human over the counter drug labeled by Olive International Inc.. This cream is formulated for topical use and contains avobenzone; homosalate; octisalate; octocrylene as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Olive International Inc. on March 25, 2025. The current certification is valid through December 31, 2027.
How is this Olive International Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85037000204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.